Pancreatic ductal adenocarcinomas (PDAC) are highly invasive and metastatic neoplasms commonly unresponsive to current drug therapy. Overwhelmingly, PDAC harbors early constitutive, oncogenic mutations in K-Ras G12D that exist prior to invasion. Histologic and genetic analyses of human PDAC biopsies also exhibit increased expression of ERK1/2, pro-invasive matrix metalloproteinases (MMPs), as well as their inhibitors tissue inhibitors of MMPs (TIMPs) - all indicators of poor prognosis. However, the distinct molecular mechanisms necessary for K-Ras - ERK1/2 signaling and its influence on stromal invasion and proliferation in primary human pancreatic ductal epithelial cells (PDECs) has yet to be elucidated in 3D. Expression of oncogenic K-RasG12D alone in genetically-defined PDECs reveals increased invadopodia, epithelial-to-mesenchymal transition markers, and hyperplasia but only when cultured in a 3D model incorporating a basement membrane. Activation of extracellular signal-related kinase 2 (ERK2), but not ERK1, also occurs only in K-RasG12D mutated PDECs cultured in 3D and is a necessary intracellular signaling event for invasion based upon pharmacologic and shRNA inhibition. Increased active invasion of K-RasG12D PDECs through the basement membrane is associated with a specific microarray gene expression signature and induction of MMP endopeptidases. Specifically, MMP-1 and TIMP-1 RNA, their secreted proteins, and MMP-1's proteolytic cleavage activity are amplified in K-RasG12D PDECs when assayed by RT q-PCR, ELISA, and fluorescence resonance energy transfer (FRET). Importantly, shRNA silencing of MMP-1 mimics ERK2 inhibition and disrupts active, vertical PDEC invasion. TIMP-1 silencing is dispensable but overexpression induces proliferation in only K-RasG12D mutated PDECs. ERK2-isoform and MMP-1 targeting are shown to be viable strategies to attenuate invasion of K-RasG12D mutated human pancreatic cancer cells in a 3D tumor microenvironment while TIMP-1 use to attenuate growth is cautioned.
Metrics
29 File views/ downloads
19 Record Views
Details
Title
Constitutive K-Ras^[G12D] activation of ERK2 specifically regulates oncogenesis of pancreatic cancer cells in 3D
Creators
Gregory P. Botta
Contributors
Peter I. Lelkes (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Doctor of Philosophy (Ph.D.)
Publisher
Drexel University; Philadelphia, Pennsylvania
Number of pages
222 pages
Resource Type
Dissertation
Language
English
Academic Unit
College of Medicine; Drexel University
Other Identifier
991014970200004721
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services